JAC Advance Access published online on January 16, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh090
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original article
1 School of Pharmacy and Pharmaceutical Sciences, University
of Manchester, Oxford Road,
Manchester M13 9PL, UK
* Corresponding author. E-mail: david.allison{at}man.ac.uk.
Received 23 July 2003
; revised 27 November 2003
; accepted 28 November 2003
Aims: To investigate the susceptibility,
to a range of different biocides, of Pseudomonas aeruginosa strains variously
deficient in N-acyl homoserine lactone systems,
grown either as planktonic or biofilm populations. Methods and results: Biocide susceptibility
data were generated for strains of P. aeruginosa deficient
in N-acyl homoserine lactone production,
grown planktonically or as biofilm populations using a poloxamer hydrogel
construct. Component cells from the biofilm constructs were also
tested for their susceptibility. Significant differences in susceptibility
were noted between the wild-type strain, a mutant defective in the long
chain (C-12) homoserine lactone and a mutant defective in the short
chain (C-4) homoserine lactone which could not be related to the
biofilm mode of growth. Moreover, differences in susceptibility
appeared to be dependent upon the nature of the homoserine lactone
deletion and type of biocide rather than the mode of growth. Conclusions: No general trend exists between
homoserine lactone deficiency and biocide susceptibility regardless
of mode of growth.
Keywords: biocide susceptibility, N-acyl
homoserine lactones, bronopol, chlorhexidine diacetate, cetrimide
USP, isothiazolones
Biofilms, homoserine lactones and biocide susceptibility
![]()
CiteULike
Connotea
Del.icio.us What's this?